(Q33501677)

English

Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG). (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Davidson A

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gowing R

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Lowis S

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Newell D

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Lewis I

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dicks-Mireaux C

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pinkerton CR

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1816-1822

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged oral etoposide in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability of low-dose oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

21-day schedule oral etoposide in children--a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of oral etoposide in children with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic daily administration of oral etoposide--a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic oral etoposide in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Variable bioavailability following repeated oral doses of etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and pharmacokinetic study of oral etoposide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900201-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00201-3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33501677&oldid=1606881089"